ZL000_00_021e_WL Guidance document Packaging for human medicinal products HMV4

First Page		Document Content
Health Pharmacology Pharmaceutical industry Pharmaceuticals policy Labels Federal Department of Home Affairs Swissmedic European Directorate for the Quality of Medicines Packaging and labeling Marketing authorization Tablet Dosage form		ZL000_00_021e_WL Guidance document Packaging for human medicinal products HMV4 Add to Reading List Source URL: www.swissmedic.ch Download Document from Source Website File Size: 594,33 KB Share Document on Facebook

	TIGes vet Q&A-update - Sept 2013 DocID: 1rsZK - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance. DocID: 1rqES - View Document
	Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \ MERGEFORMAT Annex VI: Imple DocID: 1rqtS - View Document
	Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us DocID: 1rpxR - View Document